FALLOPIAN TUBE CANCERS
Clinical trials for FALLOPIAN TUBE CANCERS explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CANCERS trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to control Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing an experimental drug called mirvetuximab soravtansine for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The main goals are to find the best dosing schedule and to see how…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo tested to control advanced ovarian cancer before surgery
Disease control Recruiting nowThis study is testing whether adding an experimental drug called TORL-1-23 to standard chemotherapy helps control advanced ovarian cancer before surgery. It will involve 60 women with newly diagnosed, advanced-stage ovarian, fallopian tube, or primary peritoneal cancer whose tumo…
Matched conditions: FALLOPIAN TUBE CANCERS
Phase: PHASE1, PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC